Search Result "pro-dopamine regulation (KB220)"


Perspective

Transmodulation of Dopaminergic Signaling to Mitigate Hypodopminergia and Pharmaceutical Opioid-induced Hyperalgesia

Journal: Current Psychopharmacology
Volume: 9 Issue: 3 Year: 2020 Page: 164-184
Author(s): Raymond Brewer,Kenneth Blum,Abdalla Bowirrat,Edward J. Modestino,David Baron,Rajendra D. Badgaiyan,Mark Moran,Brent Boyett,Mark S. Gold

Case Report

Hypodopaminergia and “Precision Behavioral Management” (PBM): It is a Generational Family Affair

Journal: Current Pharmaceutical Biotechnology
Volume: 21 Issue: 6 Year: 2020 Page: 528-541
Author(s): Lyle Fried,Edward J. Modestino,David Siwicki,Lisa Lott,Panayotis K. Thanos,David Baron,Rajendra D. Badgaiyan,Jessica V. Ponce,James Giordano,William B. Downs,Marjorie C. Gondré-Lewis,Steinberg Bruce,Eric R. Braverman,Brent Boyett,Kenneth Blum

Reward Circuitry Dopaminergic Activation Regulates Food and Drug Craving Behavior

Journal: Current Pharmaceutical Design
Volume: 17 Issue: 1 Year: 2011 Page: 1158-1167
Author(s): Kenneth Blum, Yijun Liu, Richard Shriner, Mark S. Gold

Review Article

Epigenetic Repair of Terrifying Lucid Dreams by Enhanced Brain Reward Functional Connectivity and Induction of Dopaminergic Homeo - static Signaling

Journal: Current Psychopharmacology
Volume: 10 Issue: 3 Year: 2021 Page: 170-180
Author(s): Kenneth Blum,Thomas McLaughlin,Edward J. Modestino,David Baron,Abdalla Bowirrat,Raymond Brewer,Bruce Steinberg,Alphonso K. Roy,Marcelo Febo,Rajendra D. Badgaiyan,Marks S. Gold

Perspective

Opioid Substitution Therapy: Achieving Harm Reduction While Searching for a Prophylactic Solution

Journal: Current Pharmaceutical Biotechnology
Volume: 20 Issue: 3 Year: 2019 Page: 180-183
Author(s): David Baron,Kenneth Blum

Results 1 - 1 of 5

Apply Filters

Volume Years
Article Type
    Publication Title
      Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy